1,25(OH)2D3通过稳定线粒体DNA对GCDC诱导的HiBECs凋亡的作用研究
The Role of 1,25(OH)2D3 on GCDC-Induced Apoptosis in HiBECs by Stabilising Mitochondrial DNA
摘要: 目的：探讨骨化三醇(1,25(OH)2D3)对甘氨鹅脱氧胆酸盐(GCDC)诱导的人肝内胆管上皮细胞(HiBECs)凋亡的影响，并初步阐明其潜在的作用机制。方法：采用1 nM GCDC处理HiBECs建立原发性胆汁性胆管炎细胞模型，并采用不同浓度(0.1 nM、1 nM、10 nM、100 nM) 1,25(OH)2D3处理12 h。流式细胞术检测细胞凋亡水平，ELISA检测细胞培养液中炎症因子IL-6和IL-8水平，qPCR检测PDC-E2、PGC-1α、NrF-1和NrF-2的mRNA相对表达水平，Western blot检测细胞内Bcl-2、PDC-E2表达水平。结果：1 mM GCDC可以降低HiBECs细胞增殖活性，诱导HiBECs凋亡，提高细胞培养液中IL-6和IL-8水平，上调PDC-E2蛋白表达，下调Bcl-2蛋白表达，抑制COX-1、PGC-1α、NrF-1和NrF-2 mRNA相对表达水平。可以提高GCDC诱导的HiBECs细胞增殖活性，抑制GCDC诱导HiBECs细胞凋亡，降低细胞培养液中IL-6和IL-8水平，下调PDC-E2蛋白表达水平，提高COX-1、PGC-1α、NrF-1和NrF-2 mRNA相对表达水平。结论：1,25(OH)2D3可抑制诱导HiBECs细胞凋亡，其作用机制可能与线粒体DNA稳定有关。
Abstract: Objective: To investigate the effects of osteotriol (1,25(OH)2D3) on Glycochenodeoxycholate (GCDC)-induced apoptosis of human intrahepatic biliary epithelial cells (HiBECs) and to preliminarily elucidate its potential mechanism of action. Methods: Primary biliary cholangitis cell model was established by treating HiBECs with 1 nM GCDC and treated with different concentrations (0.1 nM, 1 nM, 10 nM, 100 nM) of 1,25(OH)2D3 for 12 h. The apoptosis level was detected by flow cytometry, the levels of the inflammatory factors IL-6 and IL-8 were detected by ELISA in the cell culture fluid, and qPCR was performed to detect the relative mRNA expression levels of PDC-E2, PGC-1α, NrF-1 and NrF-2 were detected by qPCR, and the intracellular expression levels of Bcl-2 and PDC-E2 were detected by Western blot. Results: 1 mM GCDC could reduce the proliferative activity of HiBECs cells, induce apoptosis of HiBECs, increase the levels of IL-6 and IL-8 in the cell culture medium, up-regulate the expression of PDC-E2 protein, down-regulate the expression of Bcl-2 protein, and inhibit the relative expression levels of COX-1, PGC-1α, NrF-1, and NrF-2 mRNA. It can increase the proliferative activity of GCDC-induced HiBECs cells, inhibit GCDC-induced apoptosis of HiBECs cells, reduce the levels of IL-6 and IL-8 in the cell culture medium, down-regulate the level of PDC-E2 protein expression, and increase the level of COX-1, PGC-1α, NrF-1 and NrF-2 mRNA relative expression. Conclusion: 1,25(OH)2D3 can inhibit the induction of apoptosis in HiBECs, and its mechanism of action may be related to mitochondrial DNA stabilisation.
文章引用：李永新, 王战, 高炜泽, 鲁文龙, 刘明军. 1,25(OH)2D3通过稳定线粒体DNA对GCDC诱导的HiBECs凋亡的作用研究[J]. 临床医学进展, 2024, 14(4): 2256-2266. https://doi.org/10.12677/acm.2024.1441290

参考文献

[1] Carey, E.J., Ali, A.H. and Lindor, K.D. (2015) Primary Biliary Cirrhosis. The Lancet, 386, 1565-1575. [Google Scholar] [CrossRef] 
[2] Laschtowitz, A., De Veer, R.C., Van Der, Meer, A.J., et al. (2020) Diagnosis and Treatment of Primary Biliary Cholangitis. United European Gastroenterology Journal, 8, 667-674. [Google Scholar] [CrossRef] [PubMed]
[3] Li, H., Guan, Y., Han, C., Zhang, Y., Liu, Q., Wei, W. and Ma, Y. (2021) The Pathogenesis, Models and Therapeutic Advances of Primary Biliary Cholangitis. Biomedicine & Pharmacotherapy, 140, Article 111754. https://pubmed.ncbi.nlm.nih.gov/34044277/ [Google Scholar] [CrossRef] [PubMed]
[4] Spiechowicz, M., Zylicz, A., Bieganowski, P., et al. (2007) Hsp70 Is a New Target of Sgt1—An Interaction Modulated by S100A6. Biochemical and Biophysical Research Communications, 357, 1148-1153. [Google Scholar] [CrossRef] [PubMed]
[5] Rust, C., Wild, N., Bernt, C., et al. (2009) Bile Acid-Induced Apoptosis in Hepatocytes Is Caspase-6-Dependent. The Journal of Biological Chemistry, 284, 2908-2916. [Google Scholar] [CrossRef] 
[6] Arduini, A., Serviddio, G., Escobar, J., et al. (2011) Mitochondrial Biogenesis Fails in Secondary Biliary Cirrhosis in Rats Leading to Mitochondrial DNA Depletion and Deletions. American Journal of Physiology-Gastrointestinal and Liver Physiology, 301, G119-G127. [Google Scholar] [CrossRef] [PubMed]
[7] Pejznochova, M., Tesarova, M., Hansikova, H., et al. (2010) Mitochondrial DNA Content and Expression of Genes Involved in mtDNA Transcription, Regulation and Maintenance during Human Fetal Development. Mitochondrion, 10, 321-329. [Google Scholar] [CrossRef] [PubMed]
[8] Heidari, R. and Niknahad, H. (2019) The Role and Study of Mitochondrial Impairment and Oxidative Stress in Cholestasis. In: Vinken, M., Ed., Experimental Cholestasis Research. Methods in Molecular Biology, Vol. 1981, Humana, New York, 117-132. [Google Scholar] [CrossRef] [PubMed]
[9] Picca, A., Calvani, R., Coelho-Junior, H.J., et al. (2021) Cell Death and Inflammation: The Role of Mitochondria in Health and Disease. Cells, 10, Article 537. [Google Scholar] [CrossRef] [PubMed]
[10] Alexeyev, M., Shokolenko, I., Wilson, G. and LeDoux, S. (2013) The Maintenance of Mitochondrial DNA Integrity—Critical Analysis and Update. Cold Spring Harbor Perspectives in Biology, 5, Article a012641.https://pubmed.ncbi.nlm.nih.gov/23637283/ [Google Scholar] [CrossRef] [PubMed]
[11] Saki, M. and Prakash, A. (2017) DNA Damage Related Crosstalk between the Nucleus and Mitochondria. Free Radical Biology and Medicine, 107, 216-227. [Google Scholar] [CrossRef] [PubMed]
[12] Bouillon, R., Marcocci, C., Carmeliet, G., et al. (2019) Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocrine Reviews, 40, 1109-1151. [Google Scholar] [CrossRef] [PubMed]
[13] Fleet, J.C. and Schoch, R.D. (2010) Molecular Mechanisms for Regulation of Intestinal Calcium Absorption by Vitamin D and Other Factors. Critical Reviews in Clinical Laboratory Sciences, 47, 181-195. [Google Scholar] [CrossRef] [PubMed]
[14] Walker, V.P. and Modlin, R.L. (2009) The Vitamin D Connection to Pediatric Infections and Immune Function. Pediatric Research, 65, 106-113. [Google Scholar] [CrossRef] 
[15] Holick, M.F. (2007) Vitamin D Deficiency. The New England Journal of Medicine, 357, 266-281. [Google Scholar] [CrossRef] 
[16] Plum, L.A. and DeLuca, H.F. (2010) Vitamin D, Disease and Therapeutic Opportunities. Nature Reviews Drug Discovery, 9, 941-955. [Google Scholar] [CrossRef] [PubMed]
[17] Kempinska-Podhorodecka, A., Milkiewicz, M., Wasik, U., et al. (2017) Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway. International Journal of Molecular Sciences, 18, Article 289. [Google Scholar] [CrossRef] [PubMed]
[18] Banerjee, A., Athalye, S., Khargekar, N., et al. (2023) Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis. Biomedicines, 11, Article 135. [Google Scholar] [CrossRef] [PubMed]
[19] Chan, H.L.-Y., Elkhashab, M., Trinh, H., et al. (2015) Association of Baseline Vitamin D Levels with Clinical Parameters and Treatment Outcomes in Chronic Hepatitis B. Journal of Hepatology, 63, 1086-1092. [Google Scholar] [CrossRef] [PubMed]
[20] García-Álvarez, M., Pineda-Tenor, D., Jiménez-Sousa, M.A., et al. (2014) Relationship of Vitamin D Status with Advanced Liver Fibrosis and Response to Hepatitis C Virus Therapy: A Meta-Analysis. Hepatology, 60, 1541-1550. [Google Scholar] [CrossRef] [PubMed]
[21] Udomsinprasert, W., Jittikoon, J., Sukkho, S., et al. (2020) Decreased Circulating Vitamin D Reflects Adverse Outcomes of Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis. The Journal of Infection, 81, 585-599. [Google Scholar] [CrossRef] [PubMed]
[22] Tao, S., Zhang, H., Zhao, Q., et al. (2020) Correlation of Vitamin D with Inflammatory Factors, Oxidative Stress and T Cell Subsets in Patients with Autoimmune Hepatitis. Experimental and Therapeutic Medicine, 19, 3419-3424. [Google Scholar] [CrossRef] [PubMed]
[23] Reda, D., Elshopakey, G.E., Albukhari, T.A., et al. (2023) Vitamin D3 Alleviates Nonalcoholic Fatty Liver Disease in Rats by Inhibiting Hepatic Oxidative Stress and Inflammation via the SREBP-1-C/ PPARα-NF-κB/IR-S2 Signaling Pathway. Frontiers in Pharmacology, 14, Article 1164512. [Google Scholar] [CrossRef] [PubMed]
[24] Stepan, M.D., Vintilescu Ș.B., Streață, I., et al. (2023) The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome. Nutrients, 15, Article 2113. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, H., Wu, Z., Feng, F., et al. (2022) Low Vitamin D Concentrations and BMI Are Causal Factors for Primary Biliary Cholangitis: A Mendelian Randomization Study. Frontiers in Immunology, 13, Article 1055953. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, Z., Peng, C., Wang, P., et al. (2020) Serum Vitamin D Level Is Related to Disease Progression in Primary Biliary Cholangitis. Scandinavian Journal of Gastroenterology, 55, 1333-1340. [Google Scholar] [CrossRef] [PubMed]
[27] Ebadi, M., Ip, S., Lytvyak, E., et al. (2022) Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis. Nutrients, 14, Article 878. [Google Scholar] [CrossRef] [PubMed]
[28] Jiang, S., Zhang, H., Li, X., et al. (2021) Vitamin D/VDR Attenuate Cisplatin-Induced AKI by Down-Regulating NLRP3/Caspase-1/GSDMD Pyroptosis Pathway. The Journal of Steroid Biochemistry and Molecular Biology, 206, Article 105789. [Google Scholar] [CrossRef] [PubMed]
[29] Zhao, S., Zhong, Y., Xu, X. and Wan, D. (2022) 1α, 25-Dihydroxyvitamin D3 Protects Gastric Mucosa Epithelial Cells against Helicobacter pylori-Infected Apoptosis through a Vitamin D Receptor-Dependent c-Raf/MEK/ERK Pathway. Pharmaceutical Biology, 60, 801-809. [Google Scholar] [CrossRef] [PubMed]
[30] Fathi, F.E.Z.M., Sadek, K.M., Khafaga, A.F., et al. (2022) Correction to: Vitamin D Regulates Insulin and Ameliorates Apoptosis and Oxidative Stress in Pancreatic Tissues of Rats with Streptozotocin-Induced Diabetes. Environmental Science and Pollution Research International, 29, 90230. [Google Scholar] [CrossRef] [PubMed]
[31] Grünhage, F., Hochrath, K., Krawczyk, M., et al. (2012) Common Genetic Variation in Vitamin D Metabolism Is Associated with Liver Stiffness. Hepatology, 56, 1883-1891. [Google Scholar] [CrossRef] [PubMed]
[32] Petta, S., Cammà, C., Scazzone, C., et al. (2010) Low Vitamin D Serum Level Is Related to Severe Fibrosis and Low Responsiveness to Interferon-Based Therapy in Genotype 1 Chronic Hepatitis C. Hepatology, 51, 1158-1167. [Google Scholar] [CrossRef] [PubMed]
[33] Tourkochristou, E., Tsounis, E.P., Tzoupis, H., et al. (2023) The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease. International Journal of Molecular Sciences, 24, Article 11404. [Google Scholar] [CrossRef] [PubMed]
[34] Ebadi, M., Rider, E., Tsai, C., et al. (2023) Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis. Nutrients, 15, Article 576. [Google Scholar] [CrossRef] [PubMed]
[35] Hochrath, K., Stokes, C.S., Geisel, J., et al. (2014) Vitamin D Modulates Biliary Fibrosis in ABCB4-Deficient Mice. Hepatology International, 8, 443-452. [Google Scholar] [CrossRef] [PubMed]
[36] Mihaylov, S.R., Castelli, L.M., Lin, Y.-H., et al. (2023) The Master Energy Homeostasis Regulator PGC-1α Exhibits an MRNA Nuclear Export Function. Nature Communications, 14, Article No. 5496. [Google Scholar] [CrossRef] [PubMed]
[37] Rubalcava-Gracia, D., García-Villegas, R. and Larsson, N.-G. (2023) No Role for Nuclear Transcription Regulators in Mammalian Mitochondria? Molecular Cell, 83, 832-842. [Google Scholar] [CrossRef] [PubMed]
[38] Ongwijitwat, S., Liang, H.L., Graboyes, E.M., et al. (2006) Nuclear Respiratory Factor 2 Senses Changing Cellular Energy Demands and Its Silencing Down-Regulates Cytochrome Oxidase and Other Target Gene mRNAs. Gene, 374, 39-49. [Google Scholar] [CrossRef] [PubMed]
[39] Scarpulla, R.C. (2008) Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function. Physiological Reviews, 88, 611-638. [Google Scholar] [CrossRef] [PubMed]

为你推荐